Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 30, Number 7—July 2024

Volume 30, Number 7—July 2024

[PDF - 7.98 MB - 200 pages]

Perspective

Medscape CME Activity
Infectious Diseases and Clinical Xenotransplantation [PDF - 636 KB - 8 pages]
J. A. Fishman and N. J. Mueller

Xenotransplantation, transplantation into humans of vascularized organs or viable cells from nonhuman species, is a potential solution to shortages of transplantable human organs. Among challenges to application of clinical xenotransplantation are unknown risks of transmission of animal microbes to immunosuppressed recipients or the community. Experience in allotransplantation and in preclinical models suggests that viral infections are the greatest concern. Worldwide, the distribution of swine pathogens is heterogeneous and cannot be fully controlled by international agricultural regulations. It is possible to screen source animals for potential human pathogens before procuring organs in a manner not possible within the time available for surveillance testing in allotransplantation. Infection control measures require microbiological assays for surveillance of source animals and xenograft recipients and research into zoonotic potential of porcine organisms. Available data suggest that infectious risks of xenotransplantation are manageable and that clinical trials can advance with appropriate protocols for microbiological monitoring of source animals and recipients.

EID Fishman JA, Mueller NJ. Infectious Diseases and Clinical Xenotransplantation. Emerg Infect Dis. 2024;30(7):1311-1318. https://doi.org/10.3201/eid3007.240273
AMA Fishman JA, Mueller NJ. Infectious Diseases and Clinical Xenotransplantation. Emerging Infectious Diseases. 2024;30(7):1311-1318. doi:10.3201/eid3007.240273.
APA Fishman, J. A., & Mueller, N. J. (2024). Infectious Diseases and Clinical Xenotransplantation. Emerging Infectious Diseases, 30(7), 1311-1318. https://doi.org/10.3201/eid3007.240273.
Synopses

Looking Beyond the Lens of Crimean-Congo Hemorrhagic Fever in Africa [PDF - 875 KB - 7 pages]
O. Okesanya et al.

Crimean-Congo hemorrhagic fever (CCHF) is a lethal viral disease that has severe public health effects throughout Africa and a case fatality rate of 10%–40%. CCHF virus was first discovered in Crimea in 1944 and has since caused a substantial disease burden in Africa. The shortage of diagnostic tools, ineffective tick control efforts, slow adoption of preventive measures, and cultural hurdles to public education are among the problems associated with continued CCHF virus transmission. Progress in preventing virus spread is also hampered by the dearth of effective serodiagnostic testing for animals and absence of precise surveillance protocols. Intergovernmental coordination, creation of regional reference laboratories, multiinstitutional public education partnerships, investments in healthcare infrastructure, vaccine development, and a One Health approach are strategic methods for solving prevention challenges. Coordinated efforts and financial commitments are needed to combat Crimean-Congo hemorrhagic fever and improve all-around readiness for newly developing infectious illnesses in Africa.

EID Okesanya O, Olatunji G, Kokori E, Olaleke N, Adigun O, Manirambona E, et al. Looking Beyond the Lens of Crimean-Congo Hemorrhagic Fever in Africa. Emerg Infect Dis. 2024;30(7):1319-1325. https://doi.org/10.3201/eid3007.230810
AMA Okesanya O, Olatunji G, Kokori E, et al. Looking Beyond the Lens of Crimean-Congo Hemorrhagic Fever in Africa. Emerging Infectious Diseases. 2024;30(7):1319-1325. doi:10.3201/eid3007.230810.
APA Okesanya, O., Olatunji, G., Kokori, E., Olaleke, N., Adigun, O., Manirambona, E....Lucero-Prisno, D. (2024). Looking Beyond the Lens of Crimean-Congo Hemorrhagic Fever in Africa. Emerging Infectious Diseases, 30(7), 1319-1325. https://doi.org/10.3201/eid3007.230810.

Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics [PDF - 1.17 MB - 9 pages]
D. Kiiza et al.

COVID-19 vaccination was launched in March 2021 in Uganda and initially prioritized persons >50 years of age, persons with underlying conditions, healthcare workers, teachers, and security forces. However, uptake remained low 5 months after the program launch. Makerere University’s Infectious Diseases Institute supported Uganda’s Ministry of Health in optimizing COVID-19 vaccination uptake models by using point-of-care, place of worship, and place of work engagement and the Social Assistance Grant for Empowerment model in 47 of 135 districts in Uganda, where we trained influencers to support mobilization for vaccination outreach under each model. During July–December, vaccination rates increased significantly in targeted regions, from 92% to 130% for healthcare workers, 40% to 90% for teachers, 25% to 33% for security personnel, 6% to 15% for persons >50 years of age, and 6% to 11% for persons with underlying conditions. Our approach could be adopted in other targeted vaccination campaigns for future pandemics.

EID Kiiza D, Semanda J, Kawere B, Ajore C, Wasswa C, Kwiringira A, et al. Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics. Emerg Infect Dis. 2024;30(7):1326-1334. https://doi.org/10.3201/eid3007.231001
AMA Kiiza D, Semanda J, Kawere B, et al. Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics. Emerging Infectious Diseases. 2024;30(7):1326-1334. doi:10.3201/eid3007.231001.
APA Kiiza, D., Semanda, J., Kawere, B., Ajore, C., Wasswa, C., Kwiringira, A....Boore, A. (2024). Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics. Emerging Infectious Diseases, 30(7), 1326-1334. https://doi.org/10.3201/eid3007.231001.
Research

Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024 [PDF - 4.02 MB - 9 pages]
E. R. Burrough et al.

We report highly pathogenic avian influenza A(H5N1) virus in dairy cattle and cats in Kansas and Texas, United States, which reflects the continued spread of clade 2.3.4.4b viruses that entered the country in late 2021. Infected cattle experienced nonspecific illness, reduced feed intake and rumination, and an abrupt drop in milk production, but fatal systemic influenza infection developed in domestic cats fed raw (unpasteurized) colostrum and milk from affected cows. Cow-to-cow transmission appears to have occurred because infections were observed in cattle on Michigan, Idaho, and Ohio farms where avian influenza virus–infected cows were transported. Although the US Food and Drug Administration has indicated the commercial milk supply remains safe, the detection of influenza virus in unpasteurized bovine milk is a concern because of potential cross-species transmission. Continued surveillance of highly pathogenic avian influenza viruses in domestic production animals is needed to prevent cross-species and mammal-to-mammal transmission.

EID Burrough ER, Magstadt DR, Petersen B, Timmermans SJ, Gauger PC, Zhang J, et al. Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024. Emerg Infect Dis. 2024;30(7):1335-1343. https://doi.org/10.3201/eid3007.240508
AMA Burrough ER, Magstadt DR, Petersen B, et al. Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024. Emerging Infectious Diseases. 2024;30(7):1335-1343. doi:10.3201/eid3007.240508.
APA Burrough, E. R., Magstadt, D. R., Petersen, B., Timmermans, S. J., Gauger, P. C., Zhang, J....Main, R. (2024). Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024. Emerging Infectious Diseases, 30(7), 1335-1343. https://doi.org/10.3201/eid3007.240508.

Newly Recognized Spotted Fever Group Rickettsia as Cause of Severe Rocky Mountain Spotted Fever–Like Illness, Northern California, USA [PDF - 676 KB - 8 pages]
W. S. Probert et al.

The incidence of spotted fever group (SFG) rickettsioses in the United States has tripled since 2010. Rocky Mountain spotted fever, the most severe SFG rickettsiosis, is caused by Rickettsia rickettsii. The lack of species-specific confirmatory testing obfuscates the relative contribution of R. rickettsii and other SFG Rickettsia to this increase. We report a newly recognized rickettsial pathogen, Rickettsia sp. CA6269, as the cause of severe Rocky Mountain spotted fever–like illness in 2 case-patients residing in northern California. Multilocus sequence typing supported the recognition of this pathogen as a novel Rickettsia genotype most closely related to R. rickettsii. Cross-reactivity observed for an established molecular diagnostic test indicated that Rickettsia sp. CA6269 might be misidentified as R. rickettsii. We developed a Rickettsia sp. CA6269–specific real-time PCR to help resolve this diagnostic challenge and better characterize the spectrum of clinical disease and ecologic epidemiology of this pathogen.

EID Probert WS, Haw MP, Nichol AC, Glaser CA, Park SY, Campbell LE, et al. Newly Recognized Spotted Fever Group Rickettsia as Cause of Severe Rocky Mountain Spotted Fever–Like Illness, Northern California, USA. Emerg Infect Dis. 2024;30(7):1344-1351. https://doi.org/10.3201/eid3007.231771
AMA Probert WS, Haw MP, Nichol AC, et al. Newly Recognized Spotted Fever Group Rickettsia as Cause of Severe Rocky Mountain Spotted Fever–Like Illness, Northern California, USA. Emerging Infectious Diseases. 2024;30(7):1344-1351. doi:10.3201/eid3007.231771.
APA Probert, W. S., Haw, M. P., Nichol, A. C., Glaser, C. A., Park, S. Y., Campbell, L. E....Hacker, J. K. (2024). Newly Recognized Spotted Fever Group Rickettsia as Cause of Severe Rocky Mountain Spotted Fever–Like Illness, Northern California, USA. Emerging Infectious Diseases, 30(7), 1344-1351. https://doi.org/10.3201/eid3007.231771.

COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022 [PDF - 383 KB - 9 pages]
L. J. Fess et al.

Accurate and timely mortality surveillance is crucial for elucidating risk factors, particularly for emerging diseases. We compared use of COVID-19 keywords on death certificates alone to identify COVID-19 deaths in Minnesota, USA, during 2020–2022, with use of a standardized mortality definition incorporating additional clinical data. For analyses, we used likelihood ratio χ2 and median 1-way tests. Death certificates alone identified 96% of COVID-19 deaths confirmed by the standardized definition and an additional 3% of deaths that had been classified as non–COVID-19 deaths by the standardized definition. Agreement between methods was >90% for most groups except children, although agreement among adults varied by demographics and location at death. Overall median time from death to filing of death certificate was 3 days; decedent characteristics and whether autopsy was performed varied. Death certificates are an efficient and timely source of COVID-19 mortality data when paired with SARS-CoV-2 testing data.

EID Fess LJ, Fell A, O’Toole S, D’Heilly P, Holzbauer S, Kollmann L, et al. COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022. Emerg Infect Dis. 2024;30(7):1352-1360. https://doi.org/10.3201/eid3007.231522
AMA Fess LJ, Fell A, O’Toole S, et al. COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022. Emerging Infectious Diseases. 2024;30(7):1352-1360. doi:10.3201/eid3007.231522.
APA Fess, L. J., Fell, A., O’Toole, S., D’Heilly, P., Holzbauer, S., Kollmann, L....Como-Sabetti, K. (2024). COVID-19 Death Determination Methods, Minnesota, USA, 2020–2022. Emerging Infectious Diseases, 30(7), 1352-1360. https://doi.org/10.3201/eid3007.231522.

Sialic Acid Receptor Specificity in Mammary Gland of Dairy Cattle Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus [PDF - 8.54 MB - 13 pages]
R. K. Nelli et al.

In March 2024, the US Department of Agriculture’s Animal and Plant Health Inspection Service reported detection of highly pathogenic avian influenza (HPAI) A(H5N1) virus in dairy cattle in the United States for the first time. One factor that determines susceptibility to HPAI H5N1 infection is the presence of specific virus receptors on host cells; however, little is known about the distribution of the sialic acid (SA) receptors in dairy cattle, particularly in mammary glands. We compared the distribution of SA receptors in the respiratory tract and mammary gland of dairy cattle naturally infected with HPAI H5N1. The respiratory and mammary glands of HPAI H5N1–infected dairy cattle are rich in SA, particularly avian influenza virus–specific SA α2,3-gal. Mammary gland tissues co-stained with sialic acids and influenza A virus nucleoprotein showed predominant co-localization with the virus and SA α2,3-gal. HPAI H5N1 exhibited epitheliotropism within the mammary gland, and we observed rare immunolabeling within macrophages.

EID Nelli RK, Harm TA, Siepker C, Groeltz-Thrush JM, Jones B, Twu N, et al. Sialic Acid Receptor Specificity in Mammary Gland of Dairy Cattle Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerg Infect Dis. 2024;30(7):1361-1373. https://doi.org/10.3201/eid3007.240689
AMA Nelli RK, Harm TA, Siepker C, et al. Sialic Acid Receptor Specificity in Mammary Gland of Dairy Cattle Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerging Infectious Diseases. 2024;30(7):1361-1373. doi:10.3201/eid3007.240689.
APA Nelli, R. K., Harm, T. A., Siepker, C., Groeltz-Thrush, J. M., Jones, B., Twu, N....Bell, T. M. (2024). Sialic Acid Receptor Specificity in Mammary Gland of Dairy Cattle Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerging Infectious Diseases, 30(7), 1361-1373. https://doi.org/10.3201/eid3007.240689.

Electronic Health Record Data for Lyme Disease Surveillance, Massachusetts, USA, 2017–2018 [PDF - 687 KB - 6 pages]
K. Nagavedu et al.

Lyme disease surveillance based on provider and laboratory reports underestimates incidence. We developed an algorithm for automating surveillance using electronic health record data. We identified potential Lyme disease markers in electronic health record data (laboratory tests, diagnosis codes, prescriptions) from January 2017–December 2018 in 2 large practice groups in Massachusetts, USA. We calculated their sensitivities and positive predictive values (PPV), alone and in combination, relative to medical record review. Sensitivities ranged from 57% (95% CI 47%–69%) for immunoassays to 87% (95% CI 70%–100%) for diagnosis codes. PPVs ranged from 53% (95% CI 43%–61%) for diagnosis codes to 58% (95% CI 50%–66%) for immunoassays. The combination of a diagnosis code and antibiotics within 14 days or a positive Western blot had a sensitivity of 100% (95% CI 86%–100%) and PPV of 82% (95% CI 75%–89%). This algorithm could make Lyme disease surveillance more efficient and consistent.

EID Nagavedu K, Eberhardt K, Willis S, Morrison M, Ochoa A, Soliva S, et al. Electronic Health Record Data for Lyme Disease Surveillance, Massachusetts, USA, 2017–2018. Emerg Infect Dis. 2024;30(7):1374-1379. https://doi.org/10.3201/eid3007.230942
AMA Nagavedu K, Eberhardt K, Willis S, et al. Electronic Health Record Data for Lyme Disease Surveillance, Massachusetts, USA, 2017–2018. Emerging Infectious Diseases. 2024;30(7):1374-1379. doi:10.3201/eid3007.230942.
APA Nagavedu, K., Eberhardt, K., Willis, S., Morrison, M., Ochoa, A., Soliva, S....Klompas, M. (2024). Electronic Health Record Data for Lyme Disease Surveillance, Massachusetts, USA, 2017–2018. Emerging Infectious Diseases, 30(7), 1374-1379. https://doi.org/10.3201/eid3007.230942.

Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan [PDF - 1.23 MB - 10 pages]
A. Iba et al.

The increased risk for post–COVID-19 condition after the Omicron-dominant wave remains unclear. This population-based study included 25,911 persons in Japan 20–69 years of age with confirmed SARS-CoV-2 infection enrolled in the established registry system during July–August 2022 and 25,911 age- and sex-matched noninfected controls who used a self-reported questionnaire in January–February 2023. We compared prevalence and age- and sex-adjusted odds ratios of persistent COVID-19 symptoms (lasting ≥2 months). We evaluated factors associated with post–COVID-19 condition by comparing cases with and without post–COVID-19 condition. We analyzed 14,710 (8,392 cases and 6,318 controls) of 18,183 respondents. Post–COVID-19 condition proportion among cases was 11.8%, higher by 6.3% than 5.5% persistent symptoms among controls. Female sex, underlying medical conditions, mild to moderate acute COVID-19, and vaccination were associated with post–COVID-19 condition. Approximately 12% had post–COVID-19 condition during the Omicron-dominant wave, indicating the need for longer follow-up.

EID Iba A, Hosozawa M, Hori M, Muto Y, Muraki I, Masuda R, et al. Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan. Emerg Infect Dis. 2024;30(7):1380-1389. https://doi.org/10.3201/eid3007.231723
AMA Iba A, Hosozawa M, Hori M, et al. Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan. Emerging Infectious Diseases. 2024;30(7):1380-1389. doi:10.3201/eid3007.231723.
APA Iba, A., Hosozawa, M., Hori, M., Muto, Y., Muraki, I., Masuda, R....Iso, H. (2024). Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan. Emerging Infectious Diseases, 30(7), 1380-1389. https://doi.org/10.3201/eid3007.231723.

Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety [PDF - 633 KB - 8 pages]
M. Barak et al.

The COVID-19 pandemic highlighted the need for potent community-based tools to improve preparedness. We developed a community health-safety climate (HSC) measure to assess readiness to adopt health behaviors during a pandemic. We conducted a mixed-methods study incorporating qualitative methods (e.g., focus groups) to generate items for the measure and quantitative data from a February 2021 national survey to test reliability, multilevel construct, and predictive and nomologic validities. The 20-item HSC measure is unidimensional (Cronbach α = 0.87). All communities had strong health-safety climates but with significant differences between communities (F = 10.65; p<0.001), and HSC levels predicted readiness to adopt health-safety behaviors. HSC strength moderated relationships between HSC level and behavioral indicators; higher climate homogeneity demonstrated stronger correlations. The HSC measure can predict community readiness to adopt health-safety behaviors in communities to inform interventions before diseases spread, providing a valuable tool for public health authorities and policymakers during a pandemic.

EID Barak M, Wu S, Luria G, Schnyder LP, Liu R, Nguyen A, et al. Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety. Emerg Infect Dis. 2024;30(7):1390-1397. https://doi.org/10.3201/eid3007.230932
AMA Barak M, Wu S, Luria G, et al. Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety. Emerging Infectious Diseases. 2024;30(7):1390-1397. doi:10.3201/eid3007.230932.
APA Barak, M., Wu, S., Luria, G., Schnyder, L. P., Liu, R., Nguyen, A....Kaplan, C. D. (2024). Engaging Communities in Emerging Infectious Disease Mitigation to Improve Public Health and Safety. Emerging Infectious Diseases, 30(7), 1390-1397. https://doi.org/10.3201/eid3007.230932.
Dispatches

Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023 [PDF - 1.07 MB - 4 pages]
J. A. Suárez et al.

We describe a recent case of lymphatic filariasis in Colombia caused by Wuchereria bancrofti nematodes. Our study combines clinical-epidemiologic findings with phylogenetic data. Resurgence of lymphatic filariasis may be linked to increasing urbanization trends and migration from previously endemic regions. Fieldwork can be a beneficial tool for screening and containing transmission.

EID Suárez JA, Vargas-Soler JA, Manosalva-Arciniegas L, Becerra-González S, Ramirez AL, Cáceres T, et al. Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023. Emerg Infect Dis. 2024;30(7):1398-1401. https://doi.org/10.3201/eid3007.231363
AMA Suárez JA, Vargas-Soler JA, Manosalva-Arciniegas L, et al. Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023. Emerging Infectious Diseases. 2024;30(7):1398-1401. doi:10.3201/eid3007.231363.
APA Suárez, J. A., Vargas-Soler, J. A., Manosalva-Arciniegas, L., Becerra-González, S., Ramirez, A. L., Cáceres, T....Paniz-Mondolfi, A. (2024). Wuchereria bancrofti Lymphatic Filariasis, Barrancabermeja, Colombia, 2023. Emerging Infectious Diseases, 30(7), 1398-1401. https://doi.org/10.3201/eid3007.231363.

Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020 [PDF - 303 KB - 4 pages]
D. Lukoye et al.

We report that unsuccessful treatment outcomes were 11.8% for tuberculosis (TB) disease and 21.8% for TB infection among persons deprived of liberty in Uganda Prisons Service facilities. Remedial efforts should include enhancing referral networks to ensure treatment continuity, strengthening data systems for complete outcome documentation, and prioritizing short-course treatment regimens.

EID Lukoye D, Kalamya JN, Awor A, Gustavson G, Kabanda J, Ferroussier-Davis O, et al. Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020. Emerg Infect Dis. 2024;30(7):1402-1405. https://doi.org/10.3201/eid3007.230611
AMA Lukoye D, Kalamya JN, Awor A, et al. Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020. Emerging Infectious Diseases. 2024;30(7):1402-1405. doi:10.3201/eid3007.230611.
APA Lukoye, D., Kalamya, J. N., Awor, A., Gustavson, G., Kabanda, J., Ferroussier-Davis, O....Nelson, L. J. (2024). Treatment Outcomes for Tuberculosis Infection and Disease Among Persons Deprived of Liberty, Uganda, 2020. Emerging Infectious Diseases, 30(7), 1402-1405. https://doi.org/10.3201/eid3007.230611.

Relapsed Mpox Keratitis, St. Louis, Missouri, USA [PDF - 1.30 MB - 4 pages]
C. Pi et al.

We describe a case of a 46-year-old man in Missouri, USA, with newly diagnosed advanced HIV and PCR-confirmed mpox keratitis. The keratitis initially resolved after intravenous tecovirimat and penicillin for suspected ocular syphilis coinfection. Despite a confirmatory negative PCR, he developed relapsed, ipsilateral PCR-positive keratitis and severe ocular mpox requiring corneal transplant.

EID Pi C, Adah O, Cholli PA, Martines R, Abate G, Hainaut L, et al. Relapsed Mpox Keratitis, St. Louis, Missouri, USA. Emerg Infect Dis. 2024;30(7):1406-1409. https://doi.org/10.3201/eid3007.240388
AMA Pi C, Adah O, Cholli PA, et al. Relapsed Mpox Keratitis, St. Louis, Missouri, USA. Emerging Infectious Diseases. 2024;30(7):1406-1409. doi:10.3201/eid3007.240388.
APA Pi, C., Adah, O., Cholli, P. A., Martines, R., Abate, G., Hainaut, L....Poowanawittayakom, N. (2024). Relapsed Mpox Keratitis, St. Louis, Missouri, USA. Emerging Infectious Diseases, 30(7), 1406-1409. https://doi.org/10.3201/eid3007.240388.

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024 [PDF - 1.29 MB - 6 pages]
M. C. Patel et al.

Since May 2023, a novel combination of neuraminidase mutations, I223V + S247N, has been detected in influenza A(H1N1)pdm09 viruses collected in countries spanning 5 continents, mostly in Europe (67/101). The viruses belong to 2 phylogenetically distinct groups and display ≈13-fold reduced inhibition by oseltamivir while retaining normal susceptibility to other antiviral drugs.

EID Patel MC, Nguyen HT, Pascua PQ, Gao R, Steel J, Kondor RJ, et al. Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024. Emerg Infect Dis. 2024;30(7):1410-1415. https://doi.org/10.3201/eid3007.240480
AMA Patel MC, Nguyen HT, Pascua PQ, et al. Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024. Emerging Infectious Diseases. 2024;30(7):1410-1415. doi:10.3201/eid3007.240480.
APA Patel, M. C., Nguyen, H. T., Pascua, P. Q., Gao, R., Steel, J., Kondor, R. J....Gubareva, L. V. (2024). Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024. Emerging Infectious Diseases, 30(7), 1410-1415. https://doi.org/10.3201/eid3007.240480.

Reemergence of Clade IIb–Associated Mpox, Germany, July–December 2023 [PDF - 745 KB - 4 pages]
P. E. Obermeier et al.

In July 2023, clade IIb–associated mpox reemerged in Germany at low levels, mainly affecting men who have sex with men. We report a representative case and phylogeny of available genome sequences. Our findings underscore the need for standardized surveillance and indication-based vaccination to limit transmission and help prevent endemicity.

EID Obermeier PE, Plinke CF, Brinkmann A, Lachmann R, Melchert J, Corman VM, et al. Reemergence of Clade IIb–Associated Mpox, Germany, July–December 2023. Emerg Infect Dis. 2024;30(7):1416-1419. https://doi.org/10.3201/eid3007.240092
AMA Obermeier PE, Plinke CF, Brinkmann A, et al. Reemergence of Clade IIb–Associated Mpox, Germany, July–December 2023. Emerging Infectious Diseases. 2024;30(7):1416-1419. doi:10.3201/eid3007.240092.
APA Obermeier, P. E., Plinke, C. F., Brinkmann, A., Lachmann, R., Melchert, J., Corman, V. M....Buder, S. C. (2024). Reemergence of Clade IIb–Associated Mpox, Germany, July–December 2023. Emerging Infectious Diseases, 30(7), 1416-1419. https://doi.org/10.3201/eid3007.240092.

Risk for Donor-Derived Syphilis after Kidney Transplantation, China, 2007–2022 [PDF - 1.00 MB - 5 pages]
S. Yin et al.

To evaluate the risk of acquiring syphilis from a donated kidney, we evaluated kidney transplantation pairs from West China Hospital, Sichuan, China, during 2007–2022. Donor-derived syphilis was rare. Risk may be higher if donors have active syphilis and may be reduced if recipients receive ceftriaxone.

EID Yin S, Wu L, Liu C, Jia Z, Wu J, Zhang F, et al. Risk for Donor-Derived Syphilis after Kidney Transplantation, China, 2007–2022. Emerg Infect Dis. 2024;30(7):1420-1424. https://doi.org/10.3201/eid3007.240009
AMA Yin S, Wu L, Liu C, et al. Risk for Donor-Derived Syphilis after Kidney Transplantation, China, 2007–2022. Emerging Infectious Diseases. 2024;30(7):1420-1424. doi:10.3201/eid3007.240009.
APA Yin, S., Wu, L., Liu, C., Jia, Z., Wu, J., Zhang, F....Lin, T. (2024). Risk for Donor-Derived Syphilis after Kidney Transplantation, China, 2007–2022. Emerging Infectious Diseases, 30(7), 1420-1424. https://doi.org/10.3201/eid3007.240009.

Avian Influenza A(H5N1) Virus among Dairy Cattle, Texas, USA [PDF - 908 KB - 5 pages]
J. U. Oguzie et al.

During March and April 2024, we studied dairy cattle specimens from a single farm in Texas, USA, using multiple molecular, cell culture, and next-generation sequencing pathogen detection techniques. Here, we report evidence that highly pathogenic avian influenza A(H5N1) virus strains of clade 2.3.4.4b were the sole cause of this epizootic.

EID Oguzie JU, Marushchak LV, Shittu I, Lednicky JA, Miller AL, Hao H, et al. Avian Influenza A(H5N1) Virus among Dairy Cattle, Texas, USA. Emerg Infect Dis. 2024;30(7):1425-1429. https://doi.org/10.3201/eid3007.240717
AMA Oguzie JU, Marushchak LV, Shittu I, et al. Avian Influenza A(H5N1) Virus among Dairy Cattle, Texas, USA. Emerging Infectious Diseases. 2024;30(7):1425-1429. doi:10.3201/eid3007.240717.
APA Oguzie, J. U., Marushchak, L. V., Shittu, I., Lednicky, J. A., Miller, A. L., Hao, H....Gray, G. C. (2024). Avian Influenza A(H5N1) Virus among Dairy Cattle, Texas, USA. Emerging Infectious Diseases, 30(7), 1425-1429. https://doi.org/10.3201/eid3007.240717.

Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan [PDF - 448 KB - 4 pages]
T. Ogata et al.

We calculated attack rates for household contacts of COVID-19 patients during the SARS-CoV-2 Omicron BA.2–dominant period in Japan. Attack rates among household contacts without recent (<3 months) vaccination was lower for contacts of index patients with complete vaccination than for contacts of index patients without complete vaccination, demonstrating indirect vaccine effectiveness.

EID Ogata T, Tanaka H, Kon A, Sakaibori N, Tanaka E. Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan. Emerg Infect Dis. 2024;30(7):1430-1433. https://doi.org/10.3201/eid3007.230968
AMA Ogata T, Tanaka H, Kon A, et al. Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan. Emerging Infectious Diseases. 2024;30(7):1430-1433. doi:10.3201/eid3007.230968.
APA Ogata, T., Tanaka, H., Kon, A., Sakaibori, N., & Tanaka, E. (2024). Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan. Emerging Infectious Diseases, 30(7), 1430-1433. https://doi.org/10.3201/eid3007.230968.

Alongshan Virus Infection in Rangifer tarandus Reindeer, Northeastern China [PDF - 888 KB - 4 pages]
W. Xu et al.

We investigated Alongshan virus infection in reindeer in northeastern China. We found that 4.8% of the animals were viral RNA–positive, 33.3% tested positive for IgG, and 19.1% displayed neutralizing antibodies. These findings suggest reindeer could serve as sentinel animal species for the epidemiologic surveillance of Alongshan virus infection.

EID Xu W, Wang W, Li L, Li N, Liu Z, Che L, et al. Alongshan Virus Infection in Rangifer tarandus Reindeer, Northeastern China. Emerg Infect Dis. 2024;30(7):1434-1437. https://doi.org/10.3201/eid3007.231219
AMA Xu W, Wang W, Li L, et al. Alongshan Virus Infection in Rangifer tarandus Reindeer, Northeastern China. Emerging Infectious Diseases. 2024;30(7):1434-1437. doi:10.3201/eid3007.231219.
APA Xu, W., Wang, W., Li, L., Li, N., Liu, Z., Che, L....Wang, Z. (2024). Alongshan Virus Infection in Rangifer tarandus Reindeer, Northeastern China. Emerging Infectious Diseases, 30(7), 1434-1437. https://doi.org/10.3201/eid3007.231219.

Bluetongue Virus Serotype 3 and Schmallenberg Virus in Culicoides Biting Midges, Western Germany, 2023 [PDF - 1.29 MB - 4 pages]
A. Voigt et al.

In October 2023, bluetongue virus serotype 3 (BTV-3) emerged in Germany, where Schmallenberg virus is enzootic. We detected BTV-3 in 1 pool of Culicoides biting midges collected at the time ruminant infections were reported. Schmallenberg virus was found in many vector pools. Vector trapping and analysis could elucidate viral spread.

EID Voigt A, Kampen H, Heuser E, Zeiske S, Hoffmann B, Höper D, et al. Bluetongue Virus Serotype 3 and Schmallenberg Virus in Culicoides Biting Midges, Western Germany, 2023. Emerg Infect Dis. 2024;30(7):1438-1441. https://doi.org/10.3201/eid3007.240275
AMA Voigt A, Kampen H, Heuser E, et al. Bluetongue Virus Serotype 3 and Schmallenberg Virus in Culicoides Biting Midges, Western Germany, 2023. Emerging Infectious Diseases. 2024;30(7):1438-1441. doi:10.3201/eid3007.240275.
APA Voigt, A., Kampen, H., Heuser, E., Zeiske, S., Hoffmann, B., Höper, D....Werner, D. (2024). Bluetongue Virus Serotype 3 and Schmallenberg Virus in Culicoides Biting Midges, Western Germany, 2023. Emerging Infectious Diseases, 30(7), 1438-1441. https://doi.org/10.3201/eid3007.240275.

Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda [PDF - 1.36 MB - 5 pages]
P. W. Blair et al.

At 3 severe infection cohort sites in Uganda, Orientia seropositivity was common. We identified 4 seroconversion cases and 1 PCR-positive case. These results provide serologic and molecular support for Orientia spp. circulating in sub-Saharan Africa, possibly expanding its endemic range. Orientia infections could cause severe illness and hospitalizations in this region.

EID Blair PW, Kobba K, Okello S, Alharthi S, Naluyima P, Clemens E, et al. Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda. Emerg Infect Dis. 2024;30(7):1442-1446. https://doi.org/10.3201/eid3007.231040
AMA Blair PW, Kobba K, Okello S, et al. Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda. Emerging Infectious Diseases. 2024;30(7):1442-1446. doi:10.3201/eid3007.231040.
APA Blair, P. W., Kobba, K., Okello, S., Alharthi, S., Naluyima, P., Clemens, E....Illness, A. (2024). Evidence of Orientia spp. Endemicity among Severe Infectious Disease Cohorts, Uganda. Emerging Infectious Diseases, 30(7), 1442-1446. https://doi.org/10.3201/eid3007.231040.

Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran [PDF - 708 KB - 3 pages]
A. Abdoli et al.

We report the effect of a rodent control program on the incidence of zoonotic cutaneous leishmaniasis in an endemic region of Iran. A 1-year interruption in rodent control led to 2 years of increased incidence of zoonotic cutaneous leishmaniasis. Restarting rodent control led to a decline of zoonotic cutaneous leishmaniasis.

EID Abdoli A, Mazaherifar S, Solhjoo K, Zargar M, Jahromi H, Taghipour A, et al. Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran. Emerg Infect Dis. 2024;30(7):1447-1449. https://doi.org/10.3201/eid3007.231404
AMA Abdoli A, Mazaherifar S, Solhjoo K, et al. Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran. Emerging Infectious Diseases. 2024;30(7):1447-1449. doi:10.3201/eid3007.231404.
APA Abdoli, A., Mazaherifar, S., Solhjoo, K., Zargar, M., Jahromi, H., Taghipour, A....Kenarkoohi, A. (2024). Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran. Emerging Infectious Diseases, 30(7), 1447-1449. https://doi.org/10.3201/eid3007.231404.

Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020–2021 [PDF - 809 KB - 4 pages]
C. Boodman et al.

We analyzed body lice collected from persons experiencing homelessness in Winnipeg, Manitoba, Canada, during 2020–2021 to confirm vector species and ecotype and to identify louseborne pathogens. Of 556 lice analyzed from 7 persons, 17 louse pools (218 lice) from 1 person were positive for the louseborne bacterium Bartonella quintana.

EID Boodman C, Lindsay LR, Dibernardo A, Kisil K, Coatsworth H, Huynh C, et al. Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020–2021. Emerg Infect Dis. 2024;30(7):1450-1453. https://doi.org/10.3201/eid3007.231660
AMA Boodman C, Lindsay LR, Dibernardo A, et al. Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020–2021. Emerging Infectious Diseases. 2024;30(7):1450-1453. doi:10.3201/eid3007.231660.
APA Boodman, C., Lindsay, L. R., Dibernardo, A., Kisil, K., Coatsworth, H., Huynh, C....Keynan, Y. (2024). Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020–2021. Emerging Infectious Diseases, 30(7), 1450-1453. https://doi.org/10.3201/eid3007.231660.

Orthohantaviruses in Misiones Province, Northeastern Argentina [PDF - 840 KB - 5 pages]
M. Vadell et al.

Few cases of hantavirus pulmonary syndrome have been reported in northeastern Argentina. However, neighboring areas show a higher incidence, suggesting underreporting. We evaluated the presence of antibodies against orthohantavirus in small rodents throughout Misiones province. Infected Akodon affinis montensis and Oligoryzomys nigripes native rodents were found in protected areas of Misiones.

EID Vadell M, Burgos E, Lamattina D, Bellomo C, Martínez V, Coelho R, et al. Orthohantaviruses in Misiones Province, Northeastern Argentina. Emerg Infect Dis. 2024;30(7):1454-1458. https://doi.org/10.3201/eid3007.240183
AMA Vadell M, Burgos E, Lamattina D, et al. Orthohantaviruses in Misiones Province, Northeastern Argentina. Emerging Infectious Diseases. 2024;30(7):1454-1458. doi:10.3201/eid3007.240183.
APA Vadell, M., Burgos, E., Lamattina, D., Bellomo, C., Martínez, V., Coelho, R....Gómez Villafañe, I. (2024). Orthohantaviruses in Misiones Province, Northeastern Argentina. Emerging Infectious Diseases, 30(7), 1454-1458. https://doi.org/10.3201/eid3007.240183.

Rickettsia parkeri Rickettsiosis in Kidney Transplant Recipient, North Carolina, USA, 2023 [PDF - 693 KB - 4 pages]
G. M. Phadke et al.

Spotted fever rickettsiosis is rarely observed in solid organ transplant recipients, and all previously reported cases have been associated with tick bite months to years after transplantation. We describe a kidney transplant recipient in North Carolina, USA, who had a moderately severe Rickettsia parkeri infection develop during the immediate posttransplant period.

EID Phadke GM, Gajurel K, Kasten J, DeLeon-Carnes M, Ramos C, Karpathy SE, et al. Rickettsia parkeri Rickettsiosis in Kidney Transplant Recipient, North Carolina, USA, 2023. Emerg Infect Dis. 2024;30(7):1459-1462. https://doi.org/10.3201/eid3007.240217
AMA Phadke GM, Gajurel K, Kasten J, et al. Rickettsia parkeri Rickettsiosis in Kidney Transplant Recipient, North Carolina, USA, 2023. Emerging Infectious Diseases. 2024;30(7):1459-1462. doi:10.3201/eid3007.240217.
APA Phadke, G. M., Gajurel, K., Kasten, J., DeLeon-Carnes, M., Ramos, C., Karpathy, S. E....Paddock, C. D. (2024). Rickettsia parkeri Rickettsiosis in Kidney Transplant Recipient, North Carolina, USA, 2023. Emerging Infectious Diseases, 30(7), 1459-1462. https://doi.org/10.3201/eid3007.240217.

Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico [PDF - 561 KB - 4 pages]
G. Álvarez-Hernández et al.

We describe 5 children who had Rocky Mountain spotted fever (RMSF) and manifested clinical symptoms similar to multisystem inflammatory syndrome in Sonora, Mexico, where RMSF is hyperendemic. Physicians should consider RMSF in differential diagnoses of hospitalized patients with multisystem inflammatory syndrome to prevent illness and death caused by rickettsial disease.

EID Álvarez-Hernández G, Rivera-Rosas CN, Calleja-López J, McCormick DW, Paddock CD, Álvarez-Meza J, et al. Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico. Emerg Infect Dis. 2024;30(7):1463-1466. https://doi.org/10.3201/eid3007.240033
AMA Álvarez-Hernández G, Rivera-Rosas CN, Calleja-López J, et al. Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico. Emerging Infectious Diseases. 2024;30(7):1463-1466. doi:10.3201/eid3007.240033.
APA Álvarez-Hernández, G., Rivera-Rosas, C. N., Calleja-López, J., McCormick, D. W., Paddock, C. D., Álvarez-Meza, J....Correa-Morales, F. (2024). Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children, Sonora, Mexico. Emerging Infectious Diseases, 30(7), 1463-1466. https://doi.org/10.3201/eid3007.240033.

Molecular Confirmation of Anopheles stephensi Mosquitoes in the Al Hudaydah Governorate, Yemen, 2021 and 2022 [PDF - 1.74 MB - 5 pages]
M. Assada et al.

We detected malaria vector Anopheles stephensi mosquitoes in the Al Hudaydah governorate in Yemen by using DNA sequencing. We report 2 cytochrome c oxidase subunit I haplotypes, 1 previously found in Ethiopia, Somalia, Djibouti, and Yemen. These findings provide insight into invasive An. stephensi mosquitoes in Yemen and their connection to East Africa.

EID Assada M, Al-Hadi M, Esmail MA, Al-Jurban J, Alkawri A, Shamsan A, et al. Molecular Confirmation of Anopheles stephensi Mosquitoes in the Al Hudaydah Governorate, Yemen, 2021 and 2022. Emerg Infect Dis. 2024;30(7):1467-1471. https://doi.org/10.3201/eid3007.240331
AMA Assada M, Al-Hadi M, Esmail MA, et al. Molecular Confirmation of Anopheles stephensi Mosquitoes in the Al Hudaydah Governorate, Yemen, 2021 and 2022. Emerging Infectious Diseases. 2024;30(7):1467-1471. doi:10.3201/eid3007.240331.
APA Assada, M., Al-Hadi, M., Esmail, M. A., Al-Jurban, J., Alkawri, A., Shamsan, A....Carter, T. E. (2024). Molecular Confirmation of Anopheles stephensi Mosquitoes in the Al Hudaydah Governorate, Yemen, 2021 and 2022. Emerging Infectious Diseases, 30(7), 1467-1471. https://doi.org/10.3201/eid3007.240331.

Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA [PDF - 430 KB - 3 pages]
J. M. Kubiak et al.

Borrelia miyamotoi is an emerging tickborne pathogen that has been associated with central nervous system infections in immunocompromised patients, albeit infrequently. We describe a case-patient in Minnesota, USA, who had meningeal symptoms of 1 month duration. B. miyamotoi infection was diagnosed by Gram staining on cerebrospinal fluid and confirmed by sequencing.

EID Kubiak JM, Klevay M, Hilt EE, Ferrieri P. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerg Infect Dis. 2024;30(7):1472-1474. https://doi.org/10.3201/eid3007.231611
AMA Kubiak JM, Klevay M, Hilt EE, et al. Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerging Infectious Diseases. 2024;30(7):1472-1474. doi:10.3201/eid3007.231611.
APA Kubiak, J. M., Klevay, M., Hilt, E. E., & Ferrieri, P. (2024). Acute Meningoencephalitis Associated with Borrelia miyamotoi, Minnesota, USA. Emerging Infectious Diseases, 30(7), 1472-1474. https://doi.org/10.3201/eid3007.231611.
Research Letters

Pasteurella bettyae Infections in Men Who Have Sex with Men, France [PDF - 314 KB - 3 pages]
A. Li et al.

Pasteurella bettyae is a gram-negative bacillus sporadically involved in human infections; its main reservoirs are cats and dogs. A recent publication suggests the possibility of sexual transmission leading to genital infections in men who have sex with men. We report 9 cases in France of genital infection among this population.

EID Li A, Herms F, Pataut D, Louison J, Cassius C, Merimèche M, et al. Pasteurella bettyae Infections in Men Who Have Sex with Men, France. Emerg Infect Dis. 2024;30(7):1475-1477. https://doi.org/10.3201/eid3007.240352
AMA Li A, Herms F, Pataut D, et al. Pasteurella bettyae Infections in Men Who Have Sex with Men, France. Emerging Infectious Diseases. 2024;30(7):1475-1477. doi:10.3201/eid3007.240352.
APA Li, A., Herms, F., Pataut, D., Louison, J., Cassius, C., Merimèche, M....Fouéré, S. (2024). Pasteurella bettyae Infections in Men Who Have Sex with Men, France. Emerging Infectious Diseases, 30(7), 1475-1477. https://doi.org/10.3201/eid3007.240352.

Plasmodium vivax Infections among Immigrants from China Traveling to the United States [PDF - 297 KB - 3 pages]
P. Khamly et al.

Beginning in 2023, we observed increased Plasmodium vivax malaria cases at an institution in Los Angeles, California, USA. Most cases were among migrants from China who traveled to the United States through South and Central America. US clinicians should be aware of possible P. vivax malaria among immigrants from China.

EID Khamly P, Kapadia N, Umali-Wilcox M, Butler-Wu SM, Davar K. Plasmodium vivax Infections among Immigrants from China Traveling to the United States. Emerg Infect Dis. 2024;30(7):1477-1479. https://doi.org/10.3201/eid3007.240177
AMA Khamly P, Kapadia N, Umali-Wilcox M, et al. Plasmodium vivax Infections among Immigrants from China Traveling to the United States. Emerging Infectious Diseases. 2024;30(7):1477-1479. doi:10.3201/eid3007.240177.
APA Khamly, P., Kapadia, N., Umali-Wilcox, M., Butler-Wu, S. M., & Davar, K. (2024). Plasmodium vivax Infections among Immigrants from China Traveling to the United States. Emerging Infectious Diseases, 30(7), 1477-1479. https://doi.org/10.3201/eid3007.240177.

Emergence of Indigenous Dengue Fever, Niger, October 2023 [PDF - 345 KB - 3 pages]
H. Amadou et al.

Dengue fever is a growing worldwide public health concern. In mid-October 2023, multiple cases of uncommon febrile illness were reported among patients in Niamey, Niger. Fifteen samples were tested by using molecular methods, from which 7 (46.66%) were confirmed positive for mosquitoborne dengue virus belonging to serotypes 1 and 3.

EID Amadou H, Moussa S, Arzika I, Ousmane H, Amadou S, Aoula B, et al. Emergence of Indigenous Dengue Fever, Niger, October 2023. Emerg Infect Dis. 2024;30(7):1479-1481. https://doi.org/10.3201/eid3007.240301
AMA Amadou H, Moussa S, Arzika I, et al. Emergence of Indigenous Dengue Fever, Niger, October 2023. Emerging Infectious Diseases. 2024;30(7):1479-1481. doi:10.3201/eid3007.240301.
APA Amadou, H., Moussa, S., Arzika, I., Ousmane, H., Amadou, S., Aoula, B....Lagare, A. (2024). Emergence of Indigenous Dengue Fever, Niger, October 2023. Emerging Infectious Diseases, 30(7), 1479-1481. https://doi.org/10.3201/eid3007.240301.

Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024 [PDF - 488 KB - 4 pages]
S. Edouard et al.

We report a large-scale outbreak of Mycoplasma pneumoniae respiratory infections encompassing 218 cases (0.8% of 26,449 patients tested) during 2023–2024 in Marseille, France. The bacterium is currently circulating and primarily affects children <15 years of age. High prevalence of co-infections warrants the use of a syndromic diagnostic strategy.

EID Edouard S, Boughammoura H, Colson P, La Scola B, Fournier P, Fenollar F. Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024. Emerg Infect Dis. 2024;30(7):1481-1484. https://doi.org/10.3201/eid3007.240315
AMA Edouard S, Boughammoura H, Colson P, et al. Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024. Emerging Infectious Diseases. 2024;30(7):1481-1484. doi:10.3201/eid3007.240315.
APA Edouard, S., Boughammoura, H., Colson, P., La Scola, B., Fournier, P., & Fenollar, F. (2024). Large-Scale Outbreak of Mycoplasma pneumoniae Infection, Marseille, France, 2023–2024. Emerging Infectious Diseases, 30(7), 1481-1484. https://doi.org/10.3201/eid3007.240315.

Fatal Infection in Ferrets after Ocular Inoculation with Highly Pathogenic Avian Influenza A(H5N1) Virus [PDF - 880 KB - 4 pages]
J. A. Belser et al.

Ocular inoculation of a clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) virus caused severe and fatal infection in ferrets. Virus was transmitted to ferrets in direct contact. The results highlight the potential capacity of these viruses to cause human disease after either respiratory or ocular exposure.

EID Belser JA, Sun X, Pulit-Penaloza JA, Maines TR. Fatal Infection in Ferrets after Ocular Inoculation with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerg Infect Dis. 2024;30(7):1484-1487. https://doi.org/10.3201/eid3007.240520
AMA Belser JA, Sun X, Pulit-Penaloza JA, et al. Fatal Infection in Ferrets after Ocular Inoculation with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerging Infectious Diseases. 2024;30(7):1484-1487. doi:10.3201/eid3007.240520.
APA Belser, J. A., Sun, X., Pulit-Penaloza, J. A., & Maines, T. R. (2024). Fatal Infection in Ferrets after Ocular Inoculation with Highly Pathogenic Avian Influenza A(H5N1) Virus. Emerging Infectious Diseases, 30(7), 1484-1487. https://doi.org/10.3201/eid3007.240520.

Genomic Epidemiology of Large Blastomycosis Outbreak, Ontario, Canada, 2021 [PDF - 669 KB - 4 pages]
L. R. McTaggart et al.

Using phylogenomic analysis, we provide genomic epidemiology analysis of a large blastomycosis outbreak in Ontario, Canada, caused by Blastomyces gilchristii. The outbreak occurred in a locale where blastomycosis is rarely diagnosed, signaling a possible shift in geographically associated incidence patterns. Results elucidated fungal population genetic structure, enhancing understanding of the outbreak.

EID McTaggart LR, Varghese N, Sivaraman K, Patel SN, Kus JV. Genomic Epidemiology of Large Blastomycosis Outbreak, Ontario, Canada, 2021. Emerg Infect Dis. 2024;30(7):1487-1490. https://doi.org/10.3201/eid3007.231594
AMA McTaggart LR, Varghese N, Sivaraman K, et al. Genomic Epidemiology of Large Blastomycosis Outbreak, Ontario, Canada, 2021. Emerging Infectious Diseases. 2024;30(7):1487-1490. doi:10.3201/eid3007.231594.
APA McTaggart, L. R., Varghese, N., Sivaraman, K., Patel, S. N., & Kus, J. V. (2024). Genomic Epidemiology of Large Blastomycosis Outbreak, Ontario, Canada, 2021. Emerging Infectious Diseases, 30(7), 1487-1490. https://doi.org/10.3201/eid3007.231594.

Serosurvey of Chikungunya Virus in Old World Fruit Bats, Senegal, 2020–2022 [PDF - 471 KB - 3 pages]
W. M. de Souza et al.

We conducted a cross-sectional serosurvey for chikungunya virus (CHIKV) exposure in fruit bats in Senegal during 2020–2023. We found that 13.3% (89/671) of bats had CHIKV IgG; highest prevalence was in Eidolon helvum (18.3%, 15/82) and Epomophorus gambianus (13.7%, 63/461) bats. Our results suggest these bats are naturally exposed to CHIKV.

EID de Souza WM, Gaye A, Ndiaye E, Morgan AL, Sylla E, SY F, et al. Serosurvey of Chikungunya Virus in Old World Fruit Bats, Senegal, 2020–2022. Emerg Infect Dis. 2024;30(7):1490-1492. https://doi.org/10.3201/eid3007.240055
AMA de Souza WM, Gaye A, Ndiaye E, et al. Serosurvey of Chikungunya Virus in Old World Fruit Bats, Senegal, 2020–2022. Emerging Infectious Diseases. 2024;30(7):1490-1492. doi:10.3201/eid3007.240055.
APA de Souza, W. M., Gaye, A., Ndiaye, E., Morgan, A. L., Sylla, E., SY, F....Weaver, S. C. (2024). Serosurvey of Chikungunya Virus in Old World Fruit Bats, Senegal, 2020–2022. Emerging Infectious Diseases, 30(7), 1490-1492. https://doi.org/10.3201/eid3007.240055.

World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023 [PDF - 771 KB - 3 pages]
V. Ouk et al.

To determine antimicrobial susceptibility of Neisseria gonorrhoeae, we analyzed phenotypes and genomes of 72 isolates collected in Cambodia in 2023. Of those, 9/72 (12.5%) were extensively drug resistant, a 3-fold increase from 2022. Genomic analysis confirmed expansion of newly emerging resistant clones and ongoing resistance emergence across new phylogenetic backbones.

EID Ouk V, Say H, Virak M, Deng S, Frankson R, McDonald R, et al. World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023. Emerg Infect Dis. 2024;30(7):1493-1495. https://doi.org/10.3201/eid3007.240354
AMA Ouk V, Say H, Virak M, et al. World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023. Emerging Infectious Diseases. 2024;30(7):1493-1495. doi:10.3201/eid3007.240354.
APA Ouk, V., Say, H., Virak, M., Deng, S., Frankson, R., McDonald, R....Lahra, M. M. (2024). World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023. Emerging Infectious Diseases, 30(7), 1493-1495. https://doi.org/10.3201/eid3007.240354.

Serosurvey of Blood Donors to Assess West Nile Virus Exposure, South-Central Spain [PDF - 633 KB - 3 pages]
M. Frías et al.

We analyzed West Nile Virus (WNV) exposure from 1,222 blood donors during 2017–2018 from an area of south-central Spain. Results revealed WNV seroprevalence of 0.08% (95% CI 0.004%–0.4%) in this population. Our findings underscore the need for continued surveillance and research to manage WNV infection in this region.

EID Frías M, Caballero-Gómez J, Vázquez A, Madrigal E, Ruiz-Fons F, Gallo M, et al. Serosurvey of Blood Donors to Assess West Nile Virus Exposure, South-Central Spain. Emerg Infect Dis. 2024;30(7):1496-1498. https://doi.org/10.3201/eid3007.240450
AMA Frías M, Caballero-Gómez J, Vázquez A, et al. Serosurvey of Blood Donors to Assess West Nile Virus Exposure, South-Central Spain. Emerging Infectious Diseases. 2024;30(7):1496-1498. doi:10.3201/eid3007.240450.
APA Frías, M., Caballero-Gómez, J., Vázquez, A., Madrigal, E., Ruiz-Fons, F., Gallo, M....Rivero, A. (2024). Serosurvey of Blood Donors to Assess West Nile Virus Exposure, South-Central Spain. Emerging Infectious Diseases, 30(7), 1496-1498. https://doi.org/10.3201/eid3007.240450.
Books and Media

Germ Theory: Medical Pioneers in Infectious Diseases, 2nd Edition [PDF - 359 KB - 1 page]
R. N. Wofford
EID Wofford RN. Germ Theory: Medical Pioneers in Infectious Diseases, 2nd Edition. Emerg Infect Dis. 2024;30(7):1499. https://doi.org/10.3201/eid3007.231631
AMA Wofford RN. Germ Theory: Medical Pioneers in Infectious Diseases, 2nd Edition. Emerging Infectious Diseases. 2024;30(7):1499. doi:10.3201/eid3007.231631.
APA Wofford, R. N. (2024). Germ Theory: Medical Pioneers in Infectious Diseases, 2nd Edition. Emerging Infectious Diseases, 30(7), 1499. https://doi.org/10.3201/eid3007.231631.
Corrections

Correction: Vol. 28, No. 6 [PDF - 190 KB - 1 page]
EID Correction: Vol. 28, No. 6. Emerg Infect Dis. 2024;30(7):1498. https://doi.org/10.3201/eid3007.c23007
AMA Correction: Vol. 28, No. 6. Emerging Infectious Diseases. 2024;30(7):1498. doi:10.3201/eid3007.c23007.
APA (2024). Correction: Vol. 28, No. 6. Emerging Infectious Diseases, 30(7), 1498. https://doi.org/10.3201/eid3007.c23007.

Correction: Vol. 29, No. 7 [PDF - 190 KB - 1 page]
EID Correction: Vol. 29, No. 7. Emerg Infect Dis. 2024;30(7):1498. https://doi.org/10.3201/eid3007.c13007
AMA Correction: Vol. 29, No. 7. Emerging Infectious Diseases. 2024;30(7):1498. doi:10.3201/eid3007.c13007.
APA (2024). Correction: Vol. 29, No. 7. Emerging Infectious Diseases, 30(7), 1498. https://doi.org/10.3201/eid3007.c13007.
About the Cover

Poet, Politician, Exile, and Probable Malaria Victim [PDF - 1.06 MB - 3 pages]
B. Breedlove
EID Breedlove B. Poet, Politician, Exile, and Probable Malaria Victim. Emerg Infect Dis. 2024;30(7):1500-1501. https://doi.org/10.3201/eid3007.ac3007
AMA Breedlove B. Poet, Politician, Exile, and Probable Malaria Victim. Emerging Infectious Diseases. 2024;30(7):1500-1501. doi:10.3201/eid3007.ac3007.
APA Breedlove, B. (2024). Poet, Politician, Exile, and Probable Malaria Victim. Emerging Infectious Diseases, 30(7), 1500-1501. https://doi.org/10.3201/eid3007.ac3007.
Page created: June 22, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external